AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Skin patch technology may increase women's libido.(Brief Article)

Women's Health Weekly

| July 11, 2002 | COPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2002 JUL 11 - (NewsRx.com & NewsRx.net) -- "Not tonight honey, I have a headache" jokes are almost cliche. But for millions of women, it's no joke. Compounding the every day stresses of life, menopause and its subsequent declining hormone levels leave women lacking a sex drive.

Study results presented at the June 2002 10th World Congress on the Menopause by researchers from the University of Southern California suggest that transdermal (skin patch) hormone replacement therapy administration might actually improve libido in women.

"Female sexual dysfunction - low libido, slow arousal, difficulty reaching orgasms and painful intercourse - is a problem that many menopausal women view as a normal part of aging and have simply decided to accept. Where men have the choice of the little blue pill, there is a lack of treatment options for women," said Subir Roy, MD, principal investigator on the study and professor of obstetrics and gynecology at the Keck School of Medicine of the University of Southern California. The results "might be the first step in providing a new solution for postmenopausal women, since preliminary results show that HRT from a patch had positive effects on mood and libido, leading to more orgasms."

Although millions of postmenopausal women complain of decreased sex drive after menopause, there are currently no treatment methods for female sexual dysfunction. Preliminary research studies have indicated that testosterone and/or androgen supplements can have beneficial effects on women's sex drive, but none is currently approved by the U.S. Food and Drug Administration (FDA) for use in women.

"Administering testosterone or androgen therapies in women is very tricky. Since we don't have data on long-term effects and correct dosing, we often see unwanted side effects such as excessive hair growth and acne," said Roy.

"What makes our results so exciting is they indicate that HRT, when administered via a patch, allows a woman's body to better utilize the androgens, including testosterone, she already has, resulting in improved libido."

To combat ...

Related articles from newspapers, magazines, journals, and more
FDA Approves Lilly's Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The...
Press release article from: PR Newswire September 14, 2007 700+ words
...reduce invasive breast cancer risk in postmenopausal women with osteoporosis INDIANAPOLIS, Sept...invasive breast cancer in two populations: postmenopausal women with osteoporosis and postmenopausal women at high risk for invasive breast cancer...
FDA Advisory Committee Recommends Approval of EVISTA for the Reduction of Risk...
Press release article from: PR Newswire July 24, 2007 700+ words
...may provide an important option for postmenopausal women at increased risk for breast cancer...breast cancer risk in two populations: postmenopausal women with osteoporosis and postmenopausal women at high risk for breast cancer. The...
Developing profiles of postmenopausal women being prescribed estrogen therapy...
Magazine article from: Journal of Community Health Amonkar, Mayur M. Mody, Reema October 1, 2002 700+ words
ABSTRACT: Postmenopausal women with estrogen deficiency are...osteoporosis prevention among postmenopausal women. A retrospective, cross-sectional...1999, almost a third of the postmenopausal women surveyed used estrogen to prevent...
ARZOXIFENE LIFTS BMD IN POSTMENOPAUSAL WOMEN BETTER THAN EVISTA.
News wire article from: AsiaPulse News March 24, 2009 700+ words
...HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis ATHENS...Markers versus Raloxifene in Postmenopausal Women with Osteoporosis Eli Lilly...treatment of osteoporosis in postmenopausal women and the reduction of risk...
Novartis Launches Z-FAST: A Study Evaluating Femara(R) and Zometa(R) in...
Press release article from: PR Newswire December 10, 2002 700+ words
...treatment-related bone loss in postmenopausal women with early breast cancer...with cancer treatment in postmenopausal women with early breast cancer...from this information -- postmenopausal women receiving aromatase inhibitor...
Eli Lilly and Company Submits New Drug Application for EVISTA for Reduction of...
Press release article from: PR Newswire December 7, 2006 700+ words
...in risk of invasive breast cancer in postmenopausal women with osteoporosis and postmenopausal women at high risk for breast cancer. EVISTA...treatment and prevention of osteoporosis in postmenopausal women. "If approved, EVISTA would be the...
Unilocular ovarian cysts in postmenopausal women: surgery vs expectant...
Magazine article from: OB/GYN Clinical Alert Gershenson, David M. January 1, 2004 700+ words
...postmenopausal woman was abnormal...resection. Postmenopausal women weren't...cysts in postmenopausal women. In an update...lesion. No woman in this study...However, 27 women were diagnosed...study of 226 postmenopausal women with unilocular...
Lilly's Evista Associated with Significant Reduction of Cardiovascular Events...
Press release article from: Business Wire February 19, 2002 700+ words
...cardiovascular events in postmenopausal women participating in an osteoporosis...treatment of osteoporosis in postmenopausal women. Evista is currently being...events and breast cancer in postmenopausal women. The four-year cardiovascular...
FDA Approves Femara(R) (letrozole tablets) as First-Line Hormonal Treatment For...
Press release article from: PR Newswire January 10, 2001 700+ words
...first-line treatment of postmenopausal women with hormone receptor positive...metastatic breast cancer. Most postmenopausal women with advanced breast cancer...line therapy of choice for postmenopausal women with advanced breast cancer...
Newly Published Study Reveals Femara(R) Improves Chances for Harder to Treat...
Press release article from: PR Newswire April 30, 2007 700+ words
...surgical therapy, postmenopausal women with hormone...likely that a woman will die from...than 7,700 women at a median...option for postmenopausal women with early...therapy in postmenopausal women with hormone...
For more facts and information, see all results

Source: HighBeam Research, Skin patch technology may increase women's libido.(Brief Article)

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA